Nebulised Heparin for Lung Disease: Three Overlooked Risks that Merit Study Before Chronic Clinical Use

Enriched record

Fajar Farid, Haider Imran

Abstract

No public abstract is available from the verified source records.

Authors

Institutions

Provenance

crossref

Confidence 100%

ror

Confidence 99%

pubmed

Confidence 98%

europepmc

Confidence 96%

openalex

Confidence 95%

datacite

Confidence 0%

Referenced works

No local reference links have been materialized yet.

Author’s Response to: Nebulised Heparin for Lung Disease: Three Overlooked Risks that Merit Study Before Chronic Clinical Use

2026 · 0 citations

10.1007/s00408-026-00905-y

10.1007/s00408-026-00905-y · 2026

10.1128/aac.20.2.155

10.1128/aac.20.2.155 · 1981

10.1186/s40168-017-0265-7

10.1186/s40168-017-0265-7 · 2017

No additional external references are available.